700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02586

Synthetic patientMETA-24 · Day 169 · 35–44 · M · baseline S18Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
14%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S18
  2. Day 14 Trajectory diverged from prediction — Observed response fell below the model's expected path.
  3. Day 22 DT-01 recommended — Dosing / Timing Recommendation DT-01
  4. Day 23 Patient accepted — Started DT-01 in the companion
  5. Day 28 GI symptom burden −19% vs expected — Dosing / Timing Recommendation DT-01
  6. Day 34 Tolerance state changed — Unstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days
  • Inflammatory activity-7
  • Treatment adherence+4
  • Toxicity-3
  • Nutritional resilience+2

What helped?

  • Dosing / Timing Recommendation DT-01Day 22
    Result: symptom burden −19%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
43 min
stable · -0.4 vs previous 14 d
Sleep duration
Wearable
8 h
stable · -0.2 vs previous 14 d
Energy level
Daily log
6.9/10
stable · -0.1 vs previous 14 d
Steps
Wearable
4,619
stable · -23 vs previous 14 d
GI burden
Companion
20.5/100
worsening · +2.4 vs previous 14 d
Adherence
Companion
93.2 %
stable · -0.5 vs previous 14 d
Sleep quality
Wearable
74.4/100
stable · -2.1 vs previous 14 d
Glucose, CGM daily mean
CGM
122 mg/dL
stable · +2.9 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 75 from the failing basin, 23 from restoration.

Good elements to keep
  • Dosing / Timing Recommendation DT-01
    intervention · steering +13.8
  • Protein (supports)
    perturbation · steering +12.1
  • Daily walks resumed
    perturbation · steering +3.3
  • Protein
    supporter · GI -6.7 next day
Main detractors to watch
  • Low butyrate capacity
    hidden · steering -17.5
  • Simple carbohydrates
    perturbation · steering -9.9
  • Dietary fat load
    perturbation · steering -9.1
  • Ultra-processed food
    perturbation · steering -8.7
  • Simple carbohydrates
    detractor · GI +6.2 next day
  • Dietary fat load
    detractor · GI +5.4 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -6.7supporter · 95%
  • Simple carbohydrates
    +6.2detractor · 95%
  • Dietary fat load
    +5.4detractor · 95%
  • Ultra-processed food
    +5.2detractor · 95%
  • Insoluble fibre
    +2no signal · 33%
  • Caffeine
    -0.8no signal · 15%
  • Histamine load
    -0.6no signal · 15%
  • Alcohol
    -0.5no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production ↓60
    • MicrobiomeButyrate capacity 27/100
    • MicrobiomeF. prausnitzii depleted
  • Mucosal barrier integrity ↓30
    • MicrobiomeAkkermansia low → thinner mucus layer
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Intermediate metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.2 · butyrate capacity 27/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
66 ms
Sleep
7.4 h
Steps
4,466
Resting HR
70 bpm
Daily log: GI score 21, nutritional resilience 67, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
PatientSimilarityBaselineInterventionOutcomeResponse today
P-0230349%S15GI-04improved48
P-0214747%S13GI-04improved58
P-0268547%S16DT-01improved47
P-0216745%S02HY-01improved54
P-0221845%S01DT-01improved61
P-0247945%S13DT-01improved48
P-0260245%S20HY-01improved52
P-0269745%S07GI-04improved56
P-0233944%S03DT-01improved50
P-0264544%S02HY-01improved56
P-0222343%S20HY-01improved49
P-0223543%S14DT-01improved50